Medical history included hypergonadotropic hypogonadism, which had not been further investigated. He was treated for 20 years with testosterone IM once monthly, which he stopped a year before the ...
Medscape Medical News ... did not increase the risk for prostate cancer in middle-aged and older men with hypogonadism. Medscape Medical News, January 15, 2024 CMS Okays Payment for Novel AI ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback